C. Brillant

发表

Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trial.

H. Eich, R. Müller, S. Sehlen, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Combined modality treatment improves tumor control and overall survival in patients with early stage Hodgkin’s lymphoma: a systematic review

L. Specht, J. Bohlius, N. Skoetz, 2010, Haematologica.

Tenth Biannual Report of the Cochrane Haematological Malignancies Group—Focus on Acute Myeloid Leukemia

N. Skoetz, S. Kluge, A. Engert, 2009 .

First‐line double high‐dose chemotherapy and autologous stem cell transplantation versus single high‐dose chemotherapy and autologous stem cell transplantation in multiple myeloma

B. Djulbegovic, J. Bohlius, K. Wheatley, 2008 .

Sexual quality of life in Hodgkin Lymphoma: a longitudinal analysis by the German Hodgkin Study Group

P. Borchmann, H. Flechtner, A. Engert, 2013, British Journal of Cancer.

Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials.

V. Diehl, J. Raemaekers, J. Radford, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Lymphocyte-predominant and classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin Study Group.

R. Müller, V. Diehl, H. Müller-Hermelink, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Extended field radiotherapy, combined modality treatment or involved field radiotherapy for patients with stage IA lymphocyte-predominant Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Study Group (GHSG).

H. Eich, R. Müller, V. Diehl, 2005, Annals of oncology : official journal of the European Society for Medical Oncology.

Erythropoietin or Darbepoetin for patients with cancer--meta-analysis based on individual patient data.

Dirk Rades, Guido Schwarzer, Jerome Seidenfeld, 2009, The Cochrane database of systematic reviews.

Ninth Biannual Report of the Cochrane Haematological Malignancies Group--focus on hematopoietic growth factors.

N. Skoetz, S. Kluge, A. Engert, 2009, Journal of the National Cancer Institute.

Beacopp Chemotherapy for Advanced Hodgkin’s Disease: Results of Further Analyses of the HD9- and HD12- Trials of the German Hodgkin Study Group (GHSG).

R. Greil, V. Diehl, J. Franklin, 2004 .

Recent Interim Analysis of the HD11 Trial of the GHSG: Intensification of Chemotherapy and Reduction of Radiation Dose in Early Unfavorable Stage Hodgkin’s Lymphoma.

R. Greil, H. Eich, V. Diehl, 2005 .

HD10: Investigating reduction of combined modality treatment intensity in early stage Hodgkin’s lymphoma. Interim analysis of a randomized trial of the German Hodgkin Study Group (GHSG)

R. Greil, V. Diehl, L. Kanz, 2005 .

R. Greil, V. Diehl, P. Borchmann, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of BEACOPP and ABVD chemotherapy in intermediate stage Hodgkin’s lymphoma: Results of the fourth interim analysis of the HD 11 trial of the GHSG

R. Greil, H. Eich, V. Diehl, 2005 .

Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials

M. Zwahlen, M. Egger, M. Schumacher, 2009, The Lancet.

Reduction of Combined Modality Treatment Intensity in Early Stage Hodgkin’s Lymphoma: Interim Analysis of the HD 10 Trial of the GHSG.

R. Greil, H. Eich, V. Diehl, 2004 .

Dendritic Cell Based Tumor Vaccination in Prostate and Renal Cell Cancer: A Systematic Review and Meta-Analysis

M. Hellmich, M. von Bergwelt-Baildon, A. Engert, 2011, PloS one.

A Contribution to solve the problem of the need for consolidative radiotherapy after intensive chemotherapy in advanced stages of Hodgkin's lymphoma--analysis of a quality control program initiated by the radiotherapy reference center of the German Hodgkin Study Group (GHSG).

H. Eich, R. Müller, K. Hansemann, 2007, International journal of radiation oncology, biology, physics.

Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma.

N. Skoetz, A. Engert, C. Brillant, 2017, The Cochrane database of systematic reviews.

Monoclonal anti-CD20 antibodies for chronic lymphocytic leukaemia

N. Skoetz, A. Engert, O. Weingart, 2009 .

Alemtuzumab for chronic lymphocytic leukaemia

N. Skoetz, A. Engert, O. Weingart, 2009 .

Are patients with Hodgkin lymphoma and high-grade non-Hodgkin lymphoma in clinical therapy optimization protocols representative of these groups of patients in Germany?

U. Paulus, M. Löffler, C. Terschüren, 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

High‐dose chemotherapy with autologous stem cell support for first‐line treatment of aggressive non‐Hodgkin lymphoma: a systematic review and meta‐analysis based on individual patient data

G. Schwarzer, J. Bohlius, N. Skoetz, 2016 .

Comparison of chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for patients with early unfavourable or advanced stage Hodgkin lymphoma.

N. Skoetz, A. Engert, C. Brillant, 2011, The Cochrane database of systematic reviews.

Biophysical analysis of the acute toxicity of radiotherapy in Hodgkin's lymphoma--a comparison between extended field and involved field radiotherapy based on the data of the German Hodgkin Study Group.

H. Eich, R. Müller, S. Sehlen, 2004, International journal of radiation oncology, biology, physics.

V. Diehl, P. Borchmann, H. Flechtner, 2016, The Lancet. Oncology.

The effect of specialized cancer treatment centers on treatment efficacy in Hodgkin's lymphoma.

N. Skoetz, P. Borchmann, A. Engert, 2012, Deutsches Arzteblatt international.

Recombinant Human Erythropoiesis Stimulating Agents in Cancer Patients: Individual Patient Data Meta-Analysis on Behalf of the EPO IPD Meta-Analysis Collaborative Group

M. Zwahlen, M. Egger, M. Schumacher, 2008 .

Intensification of Chemotherapy and Concomitant Reduction of Radiotherapy Dose in Intermediate Stage Hodgkin′s Lymphoma: Results of the Fourth Interim Analysis of the HD 11 Trial of the GHSG.

R. Greil, H. Eich, V. Diehl, 2004 .

Combined modality treatment improves tumor control and overall survival in patients with early stage Hodgkin’s lymphoma: a systematic review

L. Specht, J. Bohlius, N. Skoetz, 2010, Haematologica.

Eleventh biannual report of the Cochrane Haematological Malignancies Group: Focus on Hodgkin lymphoma.

N. Skoetz, S. Kluge, A. Engert, 2010, Journal of the National Cancer Institute.